Welcure Drugs & Pharmaceuticals Ltd — Board Meeting, 20-05-2025: Board Meeting

Welcure Drugs & Pharmaceuticals Ltd has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025, along with the audited financial statements including the balance sheet and cash flow statement. The company will also appoint Vishakha Agrawal & Associates as the Secretarial Auditor for FY 2024-25. The trading window has been closed since April 1, 2025. This meeting is key for finalizing the company’s financial performance and compliance for the year.